Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 40 % of short-term debt in 2024; threshold 65 %.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2024.
Financials
Financial year 2024
Apotheek Hildegard from Evere, company number BE0428847688, closed financial year 2024 with a result of € 1.5 million after tax. For that financial year Apotheek Hildegard recorded a gross margin of € 2.7 million and equity of € 3.5 million. Compared with financial year 2023, the result moved from € 1.3 million to € 1.5 million. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 5, 2025.
€ 3.5 million
▼ 49% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.5 million
▲ 16% vs 2023
Profit after tax over the fiscal year.
€ 1.3 million
▼ 66% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 4.9 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2024
16.8
▲ 0.7 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 755,588
▼ 1% vs 2023
€ 45,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 126,970
▼ 35% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 14,951
▼ 95% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 357,561
▲ 21% vs 2023
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 3,691,041 | € 3,159,883 | € 2,872,547 | € 2,717,399 | ▼ 5% |
| Profit after taxes | € 2,579,083 | € 2,017,502 | € 1,289,874 | € 1,491,500 | ▲ 16% |
| Equity | € 5,755,341 | € 6,503,343 | € 6,874,310 | € 3,485,110 | ▼ 49% |
| Total debts | € 2,160,858 | € 2,048,751 | € 1,882,337 | € 5,261,192 | ▲ 180% |
| Cash | € 3,919,739 | € 2,461,142 | € 3,843,412 | € 1,307,175 | ▼ 66% |
| Land & buildings | € 2,042,052 | € 2,013,415 | € 2,051,420 | € 1,912,082 | ▼ 7% |
| Retained profit | € 5,656,183 | € 6,404,186 | € 6,775,153 | € 3,385,953 | ▼ 50% |
| Dividend | € 1,500,000 | € 1,250,000 | € 900,000 | € 4,860,000 | ▲ € 4 million |
| Balance sheet total | € 7,916,199 | € 8,552,094 | € 8,756,647 | € 8,746,302 | |
| Employees (FTE) | 16.3 | 16.8 | 16.1 | 16.8 | ▲ 0.7 |
Key figures of Apotheek Hildegard, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Apotheek Hildegard?
What happened at Apotheek Hildegard in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Wim De Marez stepped down as director. NBB
- New annual accounts for financial year 2024: profit of € 1.5 million (▲ 16% vs 2023). filed late Source: NBB ↗
- BV Wim De Marez stepped down as director. NBB
- Brigitte Pluym became a director. NBB
- Wim De Marez became a director. NBB
- BV Wim De Marez became a director. NBB
- New establishment in Evere. KBO
- Start of the company according to the CBE. KBO
In short
From € 2.6 million profit in 2021 to € 1.5 million profit in 2024.
Paid € 800,544 in corporate taxes since 2021.
Best year ever: 2021, with € 2.6 million profit.
On average € 161,700 of value added per employee in 2024.
Management
The stake of WIM DE MAREZ comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek HildegardBehind Apotheek Hildegard is Brigitte Pluym. The shares are held by WIM DE MAREZ (99.8%). It owns 100% of Medibib and 100% of KPD Pharma itself.
Directors
According to the 2024 annual accounts
since 2024
since 2023 · until 2030
since 2019 · until 2025
Shareholders
99.8%
Participations
100%
100%
Establishments
Establishment units
Physical locations of this company
H. Consciencelaan 113
1140 Evere
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0428.847.688
- VAT number
- BE 0428.847.688
- Registered office
- H. Consciencelaan 113, 1140 Evere
- Names & denominations
- Apotheek Hildegard · Apotheek Luyten
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 April 1986
- Peppol
- Active · Active since 9 Dec 2025
- Activities · NACE
Apothekers
Apotheken